Barclays’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History

Barclays’s Portfolio BSPM Stock Details BSPM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-18,300	Closed	-$41K	–	7693
2018 Q2	$41K	Buy	+18,300	New	+$45.8K	﹤0.01%	5768
2017 Q2	–	Sell	-1,000	Closed	-$2K	–	7266
2017 Q1	$2K	Buy	1,000 +530	+113%	+$1.39K	﹤0.01%	6530
2016 Q4	$1K	Sell	470 -347	-42%	-$1.19K	﹤0.01%	6557
2016 Q3	$3K	Buy	+817	New	+$2.98K	﹤0.01%	6195

Barclays's BSPM Position: Q3 2018 in Review

Barclays sold out of Biostar Pharmaceuticals, Inc. (BSPM) in Q3 2018, closing a stake of 18,300 shares — an estimated $41K sold.

Barclays first reported a position in BSPM in Q3 2016 and held it in 4 quarters. The position peaked at $41K in Q2 2018. 0 funds tracked by Wall St. Rank hold BSPM as of Q3 2018.

Barclays reported no remaining Biostar Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
Barclays sold 18,300 Biostar Pharmaceuticals, Inc. shares in Q3 2018, an estimated $41K.
Barclays first reported a position in Biostar Pharmaceuticals, Inc. in Q3 2016 and held it in 4 quarters.
Barclays's Biostar Pharmaceuticals, Inc. position peaked at $41K in Q2 2018.
0 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q3 2018.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.